The pharma giant raised the prices of 105 drugs.
Pfizer Inc PFE -1.27% , which plans a $160-billion merger with Ireland-based Allergan Plc AGN -1.22% to slash its U.S. tax bill, on Jan. 1 raised U.S. prices for more than 100 of its drugs, some by as much as 20 percent, according to statistics compiled by global information services company Wolters Kluwer.
Pfizer confirmed a 9.4% increase for heavily advertised pain drug Lyrica, which generated $2.3 billion in 2014 U.S. sales; a 12.9% increase for erectile dysfunction drug Viagra, which had 2014 U.S. sales of $1.1 billion; and a 5 percent increase for Ibrance, a novel breast cancer drug launched last year at a list price of $9,850 per month, or $118,200 per year.
Source: Pfizer Just Jacked Up Prices for All of These Drugs
Photo: Spencer Platt/Getty Images